🇺🇸 Thienopyridine in United States

27 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Acute Myocardial Infarction — 5 reports (18.52%)
  2. Blood Creatinine Increased — 3 reports (11.11%)
  3. Dyspnoea — 3 reports (11.11%)
  4. Haemorrhage — 3 reports (11.11%)
  5. Post Procedural Complication — 3 reports (11.11%)
  6. Angina Pectoris — 2 reports (7.41%)
  7. Blood Pressure Increased — 2 reports (7.41%)
  8. Blood Pressure Systolic Increased — 2 reports (7.41%)
  9. Colon Cancer — 2 reports (7.41%)
  10. Electrocardiogram St Segment Elevation — 2 reports (7.41%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Thienopyridine approved in United States?

Thienopyridine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Thienopyridine in United States?

Boston Scientific Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.